News

STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023

HORSHAM, Pa. , March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth

STRATA Skin Sciences Affirms No Exposure to Silicon Valley Bank

HORSHAM, Pa. , March 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it does not have exposure to Silicon

STRATA Skin Sciences Announces the Launch of New, Patient-Focused XTRAC® Website

Website delivers enhanced patient resources including an easy 3-step process to search, find, and communicate directly with XTRAC partner practices HORSHAM, Pa. , March 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,

STRATA Skin Sciences Announces Regaining Compliance with NASDAQ’S Minimum Price Rule

HORSHAM, Pa. , Feb. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it had been notified by Nasdaq that

STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical Conference

HORSHAM, Pa. , Feb. 16, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Joel L.

STRATA Skin Sciences Expects Record Full Year 2022 Revenue

Unaudited, preliminary revenue within the range of $35-$36 million Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa. , Feb. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,

STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference

All patients experienced a visible reduction in acne lesions HORSHAM, Pa. , Jan. 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic

STRATA Skin Sciences Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico

HORSHAM, Pa. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an exclusive agreement with MINO Labs , a